The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2022

Filed:

Oct. 31, 2019
Applicant:

Colorado State University Research Foundation, Fort Collins, CO (US);

Inventors:

Steven Dow, Littleton, CO (US);

Kathryn Wotman, Livermore, CO (US);

Lyndah Chow, Fort Collins, CO (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/14 (2006.01); A61K 39/39 (2006.01); C12N 15/117 (2010.01); A61K 47/69 (2017.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61P 37/02 (2006.01); A61K 39/12 (2006.01); A61K 49/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 8/14 (2013.01); A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 9/1272 (2013.01); A61K 39/12 (2013.01); A61K 47/6911 (2017.08); A61P 37/02 (2018.01); C12N 15/117 (2013.01); A61K 49/0054 (2013.01); A61K 49/0084 (2013.01); A61K 2039/53 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01); A61K 2039/555 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/57 (2013.01); C12N 2710/16034 (2013.01);
Abstract

Embodiments of the present invention generally relate to novel immunostimulatory compositions of use to stimulate non-specific immune responses in a subject. In certain embodiments, immunogenic compositions disclosed herein can be directed to use in the eye of a subject. In some embodiments, the immunogenic compositions disclosed herein enhance non-specific immune responses in the eye of a subject to treat or reduce the risk of onset of an eye condition. In other embodiments, compositions disclosed herein can be used to treat eye infections due to a microorganism, tumors of the eye, as well as, chronic wounds of the eye.


Find Patent Forward Citations

Loading…